Dr. Tsimberidou Discusses Improving Care

Apostolia Tsimberidou, MD, PhD
Published: Sunday, Jun 05, 2011

Lead author Apostolia M. Tsimberidou, MD, PhD, of the University of Texas MD Anderson Cancer Center, discusses how the personalized medicine program phase I trial looking at tumor molecular analysis and the use of targeted matched therapy improves the outcomes of affected patients, and cancer care in general.
Lead author Apostolia M. Tsimberidou, MD, PhD, of the University of Texas MD Anderson Cancer Center, discusses how the personalized medicine program phase I trial looking at tumor molecular analysis and the use of targeted matched therapy improves the outcomes of affected patients, and cancer care in general.

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Oncology Briefings™: Updates in Pediatric Hepatic Veno-Occlusive Disease: Integrating Novel Therapeutic Strategies to Overcome Post-Transplant ObstaclesMay 31, 20181.0
Community Practice Connections™: Working Group to Optimize Outcomes in EGFR-mutated Lung Cancers: Evolving Concepts for Nurses to Facilitate and Improve Patient CareJun 30, 20181.5
Publication Bottom Border
Border Publication
x